The European Medicines Agency has said the benefits of the Johnson & Johnson Covid-19 vaccine outweigh the risks. Use of the company's one-dose vaccine was temporarily halted by US regulators last week after a small number of blood clots were reported. More to follow...Latest coronavirus stories
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.